Mountain View, CA2 Active Studies

Ankylosing Spondylitis Clinical Trials in Mountain View, CA

Find 2 actively recruiting ankylosing spondylitis clinical trials in Mountain View, CA. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
2,560
Enrolling

Recruiting Ankylosing Spondylitis Studies in Mountain View

About Ankylosing Spondylitis Clinical Trials in Mountain View

Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.

There are currently 2 ankylosing spondylitis clinical trials recruiting participants in Mountain View, CA. These studies are seeking a combined 2,560 participants. Research is being sponsored by Merck Sharp & Dohme LLC, EyeBiotech Ltd.. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ankylosing Spondylitis Clinical Trials in Mountain View — FAQ

Are there ankylosing spondylitis clinical trials in Mountain View?

Yes, there are 2 ankylosing spondylitis clinical trials currently recruiting in Mountain View, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Mountain View?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Mountain View research site will contact you about next steps.

Are clinical trials in Mountain View free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Mountain View studies also compensate for your time and travel.

What ankylosing spondylitis treatments are being tested?

The 2 active trials in Mountain View are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.

Data updated July 23, 2026 from ClinicalTrials.gov